抗蠕虫药磷酸氯硝柳胺通过抑制同源域相互作用蛋白激酶2表达减轻肾脏纤维化
肾脏纤维化是进展性慢性肾脏病的最终共同通路,目前缺乏有效治疗。本研究在阿霉素肾病小鼠模型和单侧输尿管梗阻小鼠模型中证实,磷酸氯硝柳胺可显著减少蛋白尿、肾小球硬化病变和间质纤维化,并改善已建立的肾间质纤维化。机制上,磷酸氯硝柳胺通过干扰Smad3与HIPK2基因启动子结合,直接抑制TGF-β诱导的HIPK2表达,进而减轻下游Smad、Notch、NF-κB和Wnt/β-catenin信号通路激活。
要点
- 磷酸氯硝柳胺在阿霉素肾病小鼠中显著减少蛋白尿、肾小球硬化病变和间质纤维化。
- 磷酸氯硝柳胺在单侧输尿管梗阻小鼠中显著改善已建立的肾间质纤维化。
- 磷酸氯硝柳胺通过抑制HIPK2表达及其下游Smad、Notch、NF-κB和Wnt/β-catenin通路减轻肾纤维化。
核心结论
- 磷酸氯硝柳胺至少部分通过抑制HIPK2表达减轻肾脏纤维化,可能成为肾脏纤维化的潜在治疗药物。
研究设计与样本
- 研究采用阿霉素肾病小鼠模型和单侧输尿管梗阻小鼠模型,并在体外和体内进行机制探讨。
主要发现
- 在阿霉素肾病小鼠模型中,磷酸氯硝柳胺显著减少蛋白尿、肾小球硬化病变和间质纤维化。
- 在单侧输尿管梗阻小鼠模型中,磷酸氯硝柳胺显著改善已建立的肾间质纤维化。
- 机制上,磷酸氯硝柳胺通过干扰Smad3与HIPK2基因启动子结合,直接抑制TGF-β诱导的HIPK2表达。
- 磷酸氯硝柳胺在体外和体内均减轻HIPK2下游Smad、Notch、NF-κB和Wnt/β-catenin信号通路的激活。
临床怎么用
- 原文结论为磷酸氯硝柳胺可能成为肾脏纤维化的潜在治疗药物,未给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Renal fibrosis is the final common pathway of all varieties of progressive chronic kidney disease. However, there are no effective therapies to prevent or slow the progression of renal fibrosis. Niclosamide is a US Food and Drug Administration-approved oral antihelminthic drug used for treating most tapeworm infections. Here, we demonstrated that phosphate niclosamide, the water-soluble form of niclosamide, significantly reduced proteinuria, glomerulosclrotic lesions, and interstitial fibrosis in a murine model of adriamycin nephropathy. In addition, phosphate niclosamide significantly ameliorated established renal interstitial fibrosis a murine model of unilateral ureteral obstruction. Mechanistically, phosphate niclosamide directly inhibited TGF-β-induced expression of homeodomain-interacting protein kinase 2 (HIPK2) by interfering with the binding of Smad3 to the promoter of the HIPK2 gene, and subsequently mitigated the activation of its downstream signaling pathways including Smad, Notch, NF-κB and Wnt/β-catenin pathway both in vitro and in vivo. Thus, phosphate niclosamide mitigates renal fibrosis at least partially by inhibiting HIPK2 expression. Hence, phosphate niclosamide might be a potential therapeutic agent for renal fibrosis.
引用
- Chang X, Zhen X, Liu J, et al. The antihelmenthic phosphate niclosamide impedes renal fibrosis by inhibiting homeodomain-interacting protein kinase 2 expression. Kidney Int. 2017. PMID: 28318631. doi:10.1016/j.kint.2017.01.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。